Evaluation of the Drug-Resistant Tuberculosis Surveillance System, Brazil, 2013-2017. / Avaliação do Sistema de Vigilância da Tuberculose Drogarresistente, Brasil, 2013-2017.
Epidemiol Serv Saude
; 29(1): e2019190, 2020.
Article
em En, Pt
| MEDLINE
| ID: mdl-32159621
ABSTRACT
OBJECTIVE:
to evaluate the Brazilian Drug-Resistant Tuberculosis Surveillance System (DRTB-SS).METHODS:
this was an evaluative study, following Centers for Disease Control and Prevention guidelines, using national data from the Special Tuberculosis Treatment Information System (SITETB), and the Notifiable Diseases Information System (SINAN), from 2013 to 2017.RESULTS:
average data completeness was 95% (schooling [89.1%; 5,417/6,078], nationality [94.7%; 5,754/6,078], race/skin color [99.1%; 6,023/6,078], type of resistance [98.6%; 5,995/6,078], clinical form [100%; 6,078/6,078], and HIV test [87%; 5,289/6,078]); average proportion of cases with sputum cultures performed was 65.7% (culture 1 [94.8%; 5,764/6,078], culture 2 [69.8%; 4,241/6,078], culture 3 [54.7%, 3,324/6,078], and culture 4 [43.6%; 2,652/6,078]); DRTB-SS reported 52% (1,197/2,300) of multi-resistant cases estimated by the World Health Organization in 2015, 41.3% (990/2,400) in 2016, and 45.8% (1,100/2,400) in 2017.CONCLUSION:
low DRTB-SS sensitivity suggests the need for improved access to DRTB diagnosis.
Texto completo:
1
Coleções:
01-internacional
Temas:
Aperfeicoar_gestao_SUS
Contexto em Saúde:
11_ODS3_cobertura_universal
/
1_ASSA2030
/
2_ODS3
/
3_ND
/
4_TD
Base de dados:
MEDLINE
Assunto principal:
Tuberculose Resistente a Múltiplos Medicamentos
/
Notificação de Doenças
/
Vigilância em Saúde Pública
/
Sistemas de Informação em Saúde
Tipo de estudo:
Diagnostic_studies
/
Guideline
/
Screening_studies
Limite:
Adult
/
Female
/
Humans
/
Male
País/Região como assunto:
America do sul
/
Brasil
Idioma:
En
/
Pt
Revista:
Epidemiol Serv Saude
Ano de publicação:
2020
Tipo de documento:
Article